Search clinical trials for: Chelation therapy

Total 21657 results

Haukeland University Hospital
Novartis

Withdrawn

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome (DefeHEMY)

Myelodysplastic Syndromes | Hemochromatosis

Norway
Chiesi Canada Corp

No longer available

Compassionate Use of Deferiprone in Patients With PKAN

Pantothenate Kinase-Associated Neurodegeneration
TauTona Group

Withdrawn

Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment (D-SCOUT)

Sickle Cell Disease | Chronic Cutaneous Ulcer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Novartis Pharmaceuticals

Terminated

Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome

Anemia | Myelodysplastic Syndrome

United States
CorMedix

Completed

Deferiprone for the Prevention of Contrast-Induced Acute Kidney Injury

Contrast-Induced Acute Kidney Injury

United States
JSR Medical Co., Ltd.

Recruiting

Safety and Effectiveness Evaluations of the COLO-BT as an Treatment to the Proctectomy. (COLO-BT)

Colorectal Cancer | Colorectal Surgery | Rectal/Anal

United States
Washington University School of Medicine

Completed

The Bladder Flap at Cesarean Section: A Randomized Controlled Trial

Cesarean Section

United States
Shanghai Changzheng Hospital
First Affiliated Hospital of Zhejiang University; The First Affiliated Hospital... and other collaborators

Unknown

Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis (DACAPO)

Venous Thrombosis | Central Venous Catheter Thrombosis | Renal Failure Chronic Requiring Hemodialysis | Venous Stenosis | Central Venous Catheterization | Inadequate Hemodialysis Blood Flow | Infection Due to Central Venous Catheter
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Unknown

Patient-ventilator Asynchrony During Noninvasive Ventilation Assessed Using Diaphragm Ultrasonography (ADULT)

Ultrasonography | Diaphragm

France
Hadassah Medical Organization

Withdrawn

Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation

Myelodysplastic Syndromes | Myelofibrosis

Israel
University Hospital, Lille

Completed

Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease (FAIR-PARK-I)

Parkinson's Disease

France
ApoPharma

Completed

Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients

Iron Overload

Egypt, Indonesia, Malaysia
Robert Lodder
University of Kentucky

Completed

Naturlose (D-Tagatose) Efficacy Evaluation Trial (NEET)

Type 2 Diabetes

United States, India
ApoPharma

Completed

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

Hepatic Impairment

United States
ApoPharma

Completed

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

HIV Infection

South Africa
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Novartis Pharmaceuticals

Completed

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Beta-Thalassemia

United States
Wageningen University
Kenya Medical Research Institute; Akzo Nobel; Unilever Food and Health Research...

Completed

Iron-fortified Whole Maize Flour Trial

Anaemia
Rehabilitation Hospital of Overland Park
Discovery Statistics

Recruiting

IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study

Neurologic Disorder

United States
Karolinska University Hospital

Not yet recruiting

Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers (DEFEHU)

Diabetic Foot Ulcer
Brigham and Women's Hospital
National Institute on Aging (NIA)

Completed

Modulation of Cerebral Blood Flow Using Iron Chelators (DFO)

Stroke | Problem of Aging

United States
Willy Halim

Unknown

Is Treatment of the Intervertebral Disc More Effective at Short-term Than the Nerve Root in Patients With a Neck Hernia?

Contained Cervical Disc Herniation

Netherlands
University of Calgary
ArthroCare Corporation; Calgary Health Region

Unknown

Coblation-Tonsillotomy vs Electrocautery-Tonsillectomy for the Treatment of Obstructive Sleep Apnea (OSA) in Children

Obstructive Sleep Apnea

Canada
The University of Texas Health Science Center at...

Withdrawn

A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Hormozgan University of Medical Sciences

Completed

Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload

Iron Overload | Thalassemia | Transfusion Related Complications

Iran, Islamic Republic of
ArthroCare Corporation

Completed

Plantar Fasciosis Treatment Using Coblation

Plantar Fasciitis

United States
Kaiser Permanente

Withdrawn

Comparison of Floseal Hemostasis Tonsillectomy With Coblation Tonsillectomy and Cautery Hemostasis Tonsillectomy

Obstructive Sleep Apnea | Tonsillitis | Adenotonsillar Hypertrophy
University Hospital, Bordeaux

Recruiting

Iron Chelation in the Prevention of Secondary Degeneration After Stroke (CHEL-IC)

Stroke

France
Germans Trias i Pujol Hospital
Fundació Institut Germans Trias i Pujol

Completed

Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion (TANDEM-1)

Ischemic Stroke, Acute

Spain
ApoPharma

Completed

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration (TIRCON-EXT)

Pantothenate Kinase-Associated Neurodegeneration

United States, Germany, Italy, United Kingdom
Kafrelsheikh University

Recruiting

Anchor Versus Parachute Suturing Technique in Arteriovenous Fistula Creation for Hemodialysis

Arterio-venous Fistula

Egypt
Juergen Debus

Recruiting

Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors (NAVIGATORR)

Head and Neck Tumors

Germany
Centre Hospitalier Universitaire de Nīmes

Recruiting

Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy (PROSTED)

Prostate Cancer

France
ApoPharma

Terminated

Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias

Iron Overload | Sickle Cell Disease | Other Anemias

United States, United Kingdom, Egypt, Canada, Saudi Arabia
Kasr El Aini Hospital
Eyecare Center

Completed

Comparison Between the SBK Microkeratome Versus Femtosecond Laser in Flap Creation During LASIK Surgery for Myopia

Refractive Surgery

Egypt
Aditya S. Pandey, MD
Michigan Medicine PKUHSC Joint Institute for Translational & Clinical Research

Recruiting

Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) (DISH)

Aneurysmal Subarachnoid Hemorrhage

United States, China
Hesham Al-Inany

Unknown

Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection

Covid 19
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Heart Diseases | Cardiovascular Diseases | Beta-Thalassemia

United States
ApoPharma

Completed

Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease

Sickle Cell Disease

Canada
Ospedale Microcitemico
Azienda Sanitaria Locale di Cagliari

Completed

Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major (DFODFPTM)

Iron Overload | Cardiomyopathy

Italy
RESnTEC, Institute of Research

Completed

Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload

Pateints of β-thalassemia Major With Iron Overload

Pakistan
Novartis Pharmaceuticals

Completed

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Transfusion-dependent Anemia

Egypt, Hungary, Turkey, United States, Bulgaria, Italy, Belgium, Russian Federation, Philippines, France, Malaysia, India, Oman, Panama, Lebanon, Thailand, Tunisia
University Hospital, Lille
European Commission; ApoPharma

Completed

Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease (FAIRPARKII)

Parkinson Disease

Netherlands, Spain, France, Portugal, Czechia, United Kingdom, Austria, Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload (HYPERION)

Cardiac Iron Overload

Taiwan, Egypt, Thailand, Turkey, United Kingdom, Italy, Canada, Greece
Novartis Pharmaceuticals

Completed

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

Anemia, Sickle Cell

United States
ApoPharma

Completed

Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers

Healthy

Canada
Lipomed

Completed

Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

Hemochromatosis

Egypt, Turkey
Weill Medical College of Cornell University

Unknown

Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both

Thalassemia

United States
ApoPharma
Food and Drug Administration (FDA)

Completed

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

Pantothenate Kinase-Associated Neurodegeneration

United States, Germany, Italy, United Kingdom
Hospices Civils de Lyon

Unknown

Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (GREFFE)

Myelodysplastic Syndromes | Myeloid Leukemia

France

Search clinical trials for: Chelation therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations